Wall, Matthew A.
Turkarslan, Serdar
Wu, Wei-Ju
Danziger, Samuel A.
Reiss, David J.
Mason, Mike J.
Dervan, Andrew P. http://orcid.org/0000-0002-6482-8654
Trotter, Matthew W. B.
Bassett, Douglas
Hershberg, Robert M.
Lomana, Adrián López García de
Ratushny, Alexander V. http://orcid.org/0000-0002-1701-4084
Baliga, Nitin S. http://orcid.org/0000-0001-9157-5974
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIH NIAID R01 AI141953, NIH NIAID R01 AI141953, NIH NIAID R01 AI141953, NIH NIAID R01 AI141953, NIH NIAID R01 AI141953)
Additional funding from Institute for Systems Biology and Celgene/BMS
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
National Science Foundation (NSF ABI 1565166)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 1 August 2020
Accepted: 13 May 2021
First Online: 28 June 2021
Competing interests
: S.A.D., D.J.R., A.P.D., M.W.B.T., D.B., and A.V.R. declare employment and equity ownership for Bristol-Myers Squibb Corporation. R.M.H. declares former employment and equity ownership for Celgene Corporation; membership on an entity’s Board of Directors or advisory committee for Adaptive Biotechnologies and NanoString Technologies; consultancy at Fraizer Healthcare Partners.